Haematologica

Displaying 1 - 11 of 11
Shah, N. N., Wang, M., Roeker, L. E., Patel, K., Woyach, J. A., Wierda, W. G., Ujjani, C. S., Eyre, T. A., Inzani, P. L. Z., Alencar, A. J., Ghia, P., Lamanna, N., Hoffmann, M. S., Patel, M. R., Flinn, I., Gerson, J. N., Ma, S., Coombs, C. C., Cheah, C. Y., … Brown, J. R. (2024). Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial. Haematologica. https://doi.org/10.3324/haematol.2024.285754
Publication Date
Myers, C. S., Williams, E., Cornejo, C. B., Pongas, G., Toomey, N. L., Sanches, J. A., Battistella, M., Mo, S., Pulitzer, M., Moskaluk, C. A., Bhagat, G., Ofori, K., Davick, J. J., Servitje, O., Miyashiro, D., Climent, F., Ringbloom, K., Duenas, D., Law, C., … Ramos, J. C. (2024). Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations. Haematologica. https://doi.org/10.3324/haematol.2024.285233
Publication Date
Riabov, V., Xu, Q., Schmitt, N., Streuer, A., Ge, G., Bolanos, L., Wunderlich, M., Jann, J.-C., Wein, A., Altrock, E., Demmerle, M., Mukherjee, S., Ali, A. M., Rapp, F., Nowak, V., Weimer, N., Obländer, J., Palme, I., Göl, M., … Nowak, D. (2023). <i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. Haematologica, 0–0. https://doi.org/10.3324/haematol.2023.282921
Publication Date
Hammons, L., Szabo, A., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Dhakal, B., Al Hadidi, S., Radhakrishnan, S. V., Narra, R., Bhutani, D., Thanendrarajan, S., Janz, S., Zangari, M., Lentzsch, S., Van Rhee, F., Crescencio, J. C. R., D’Souza, A., Chakraborty, R., Mohan, M., & Schinke, C. (2023). The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. Haematologica, 109(3), 906–914. https://doi.org/10.3324/haematol.2023.283590
Publication Date
Brown, J. R., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, H., & Tedeschi, A. (2024). Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. Haematologica. https://doi.org/10.3324/haematol.2023.283846
Publication Date
Baruchel, A., Bourquin, J.-P., Crispino, J., Cuartero, S., Hasle, H., Hitzler, J., Klusmann, J.-H., Izraeli, S., Lane, A. A., Malinge, S., Rabin, K. R., Roberts, I., Ryeom, S., Tasian, S. K., & Wagenblast, E. (2023). Down syndrome and leukemia: from basic mechanisms to clinical advances. Haematologica, 108(10), 2570–2581. https://doi.org/10.3324/haematol.2023.283225
Publication Date
Thomas, T. A., Qiu, A., Kim, C. Y., Gordy, D. E., Miller, A., Tredicine, M., Dzieciatkowska, M., Dei Zotti, F., Hod, E. A., D’Alessandro, A., Zimring, J. C., Spitalnik, S. L., & Hudson, K. E. (2023). Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica, 108(10), 2639–2651. https://doi.org/10.3324/haematol.2023.282815
Publication Date
Murthy, G. S. G., Kim, S., Estrada-Merly, N., Abid, M. B., Aljurf, M., Assal, A., Badar, T., Badawy, S. M., Ballen, K., Beitinjaneh, A., Cerny, J., Chhabra, S., DeFilipp, Z., Dholaria, B., Perez, M. A. D., Farhan, S., Freytes, C. O., Gale, R. P., Ganguly, S., … Saber, W. (2023). Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica, 108(7), 1900–1908. https://doi.org/10.3324/haematol.2022.281958
Publication Date
Wayne, A. S., Huynh, V., Hijiya, N., Rouce, R. H., Brown, P. A., Krueger, J., Kitko, C. L., Ziga, E. D., Hermiston, M. L., Richards, M. K., Baruchel, A., Schuberth, P. C., Rossi, J., Zhou, L., Goyal, L., Jain, R., Vezan, R., Masouleh, B. K., & Lee, D. W. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica, 108(3), 747–760. https://doi.org/10.3324/haematol.2022.280678
Publication Date
Leeman-Neill, R. J., Soderquist, C. R., Montanari, F., Raciti, P., Park, D., Radeski, D., Mansukhani, M. M., Murty, V. V., Hsiao, S., Alobeid, B., & Bhagat, G. (2020). Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. Haematologica, 107(1), 201–210. https://doi.org/10.3324/haematol.2020.267294
Publication Date